This document reports findings regarding the use of patents data for understanding various dimensions of technical change in health-related areas. Reported counts are based on “Triadic Patent Families”, that is sets of patents covering a single invention, filed altogether in Europe, Japan and the US. There were nearly 40 000 health-related patent families filed in the 1988-1995 period, which is 16% of the total number of patent families, with a majority (58%) of Medical Preparations (mainly drugs), followed by Surgery (13%), Media Devices (10%) and Prostheses (9%). The share of health patent inventors residing in the US is 56% (it is 35% in all families), EU is 27% (32% in all families), and Japan is 11% (28% in all families). The share of the US has been increasing between 1988 and 1995, whereas the share of Japan was shrinking. Internationalisation of research (measured by the share of patents with inventors residing in two or more different countries) has been growing steadily ... Ce document etudie les enseignements qui peuvent etre tires de l’utilisation des brevets pour comprendre differentes dimensions du progres technique dans les domaines lies a la sante. Les comptages sont bases sur les “familles triadiques de brevets”, qui sont des ensembles de brevets couvrant une meme invention, demandes a la fois en Europe, aux Etats-Unis et au Japon. Il y a eu environ 40 000 familles de brevets demandees au cours de la periode 1988-1995, soit 16% du nombre total de familles, avec une majorite (58%) de Preparations medicales (principalement des medicaments), suivies par la Chirurgie (13%), les Dispositifs d’introduction (10%) et les Protheses (9%). La part des inventeurs de brevets lies a la sante residant aux Etats-Unis est de 56% (elle est de 35% pour l’ensemble des familles), la part de l’UE est de 27% (32% pour l’ensemble des familles), et celle du Japon est de 11% (28% pour l’ensemble des familles). La part des Etats-Unis s’est accrue entre 1988 et ...
[1]
Sidney A. Jaffe.
A price index for deflation of academic R & D expenditures
,
1972
.
[2]
Z. Griliches,et al.
Who Does R&D and Who Patents?
,
1982
.
[3]
I. Cockburn,et al.
Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery
,
2003
.
[4]
R. Evenson,et al.
International Invention: Implications for Technology Market Analysis
,
1984
.
[5]
I. Cockburn,et al.
Scale, scope, and spillovers: the determinants of research productivity in drug discovery.
,
1996,
The Rand journal of economics.
[6]
A. Pakes,et al.
Patents and R&D at the Firm Level: A First Look
,
1984
.